Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Mulroy Michael H.
Director at Lineage Cell Therapeutics. Filing since 24 Mar 2022.
CIK 0001509725
Company
Date
Role
Action
Shares
Amount
Of holding
LCTX
Lineage Cell Therapeutics, Inc.
22 Nov 2024
Director
Bought
40,000
$22.64K
15.5%
LCTX
Lineage Cell Therapeutics, Inc.
24 Mar 2022
Director
Bought
7,000
$9.80K
2.8%
2 decisions on file.
